02/18/2025
5:00 AM | Fogarty Siobhan (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2025
4:05 PM | L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
7:52 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
6:09 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
6:39 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
1:56 PM | SABBY MANAGEMENT, LLC (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
12/23/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:16 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
12/20/2024
3:17 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TNXP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/17/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
3:13 PM | Tonix Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/03/2024
4:15 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
12/03/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:10 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
4:10 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:30 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:30 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
8:01 AM | Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/16/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
11:15 PM | Tonix Pharmaceuticals (Filer)
| Form EFFECT | |
09/27/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:09 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
09/23/2024
6:08 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
4:03 PM | Tonix Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/19/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
6:23 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
4:00 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
09/10/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
4:17 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
08/30/2024
4:08 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
6:02 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Three new patents reveal Elon and Trump’s secret “Project America” (Ad) Right now for a limited time…
You can get Tim Bohen’s top 5 Trump stocks for 2025…
For only ONE DOLLAR!
He says these 5 stocks are trading for less than $2 right now…
But they could soon SOAR in Trump’s first 100 days. Get the names and tickers now for $1 |
08/19/2024
5:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:18 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/15/2024
5:03 AM | Tonix Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/12/2024
7:18 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:22 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:08 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:17 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/25/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
4:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
07/16/2024
8:12 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:48 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:33 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/08/2024
4:01 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/08/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
5:45 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:09 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
3:52 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
3:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
06/13/2024
4:24 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/10/2024
7:53 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
10:21 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
4:10 PM | Taylor Carolyn E. (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Tonix Pharmaceuticals (Issuer)
Treco James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
7:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:56 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form ARS | |
04/15/2024
3:38 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
04/05/2024
3:47 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
03/29/2024
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
03/29/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:03 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
8:23 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
8:48 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:01 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4/A | |
03/06/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:05 PM | SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:06 PM | MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:07 PM | SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia > DeepSeek (Ad) Everyone's getting it all wrong …
Sure, DeepSeek's reveal caused AI stocks to tumble …
But, in the long run … that's a good thing. Click here to see why Nvidia's bad day could end up being a great year. |
02/29/2024
4:08 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
7:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
